Friday, January 4, 2019
Six weeks after canning its Novartis-partnered, glucose-sensing contact lens project, Verily is raising a $1 billion round that will power new partnerships, “global business development opportunities” and potential acquisitions.
Friday, January 4, 2019
Hoping to push on with its work on next-gen eye treatments, Oculis has raised an extra CHF 15 million ($15.2 million) as it looks to fellow native Swiss biopharma Novartis for its next project.
Friday, January 4, 2019
Sanofi is set to invest €80 million ($91 million) in BioNTech and extend its cancer collaboration with the German mRNA specialist. The agreement comes as BioNTech and Sanofi prepare to start clinical development of the first cancer immunotherapy to emerge from their 2015 pact.
Friday, January 4, 2019
Cancer immunotherapy company Tizona Therapeutics is starting 2019 with a new CEO and a strategic collaboration with AbbVie that has swelled its coffers with a hefty upfront payment.
Friday, January 4, 2019
The once highly secretive Ribon Therapeutics has come out with a chunky series B with a focus on monoPARPs against cancer, inflammatory disorders and neurodegenerative diseases.
Friday, January 4, 2019
Built on an existing partnership, Celgene contributes to Antengene's $120 million series B; Otsuka teams up with Click Therapeutics over digital medicine; Chinese firms MabSpace and HJB merge to create a new biologics specialist; and more.
Friday, January 4, 2019
AbbVie streamlined its management team to four executives, the FDA tapped Flatiron’s Amy Abernethy for an oversight post and PPD beefed up its therapeutics team with new leadership. Those moves plus more hirings, firings and retirings throughout the industry.
Presented by: Aprecia
Get ahead of looming challenges in the market that include both generic products and new branded drugs.
Sponsored by: Oracle Health Sciences
New infographic shows trends in clinical development and the impact on randomization and trial supply management technology (RTSM).
Sponsored by: Veeva
Reduce the effort to create submissions and track registrations with a move to unified RIM. Watch the on-demand webinar.
Sponsored by: DocuSign
Life sciences companies must immediately identify and realize productivity gains to drive down operational costs—or risk seeing more nimble competitors disappear into the distance. Where to begin?
Sponsored by: Veeva
Learn how to spot an imposter with an integrated suite vs. one that’s unified. Read this whitepaper to learn more.
Sponsored by: Outer Edge Technology
Outer Edge Technology specializes in designing and managing regulated cloud-based infrastructures for the Life Sciences Industry – typically leveraging the AWS and Microsoft Azure platforms.
Sponsored by: Biotech Primer
The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry.
